Gallbladder DiseaseSymptoms, Doctors, Treatments, Advances & More
Learn About Gallbladder Disease
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Shishir Maithel is a Surgical Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 26 years. Dr. Maithel is rated as an Elite provider by MediFind in the treatment of Gallbladder Disease. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Hepatectomy. Dr. Maithel is board certified in American Board Of Surgery - Surgery (Certified).
Vanderbilt-Ingram Cancer Center
Kamran Idrees is a Colorectal Surgeon practicing medicine in Nashville, Tennessee. Dr. Idrees is rated as an Elite provider by MediFind in the treatment of Gallbladder Disease. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Gallbladder Cancer, Pancreaticoduodenectomy, and Pancreatectomy.
UT Southwestern Surgical Oncology Clinic
Cecilia Ethun is a Surgical Oncologist and a General Surgeon practicing medicine in Dallas, Texas. Dr. Ethun is rated as an Elite provider by MediFind in the treatment of Gallbladder Disease. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Gallbladder Cancer, Gallbladder Disease, Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Removal, and Pancreaticoduodenectomy.
Summary: Laparoscopic cholecystectomy is still considered the gold standard for the surgical management of gallbladder disease due to its minimally invasive nature, shorter recovery time, and reduced postoperative complications. Despite these advantages, patients frequently experience moderate to severe postoperative pain, particularly in the early postoperative period, which can impede recovery, delay mob...
Summary: The ANTARES study is a phase II basket trial designed to evaluate the tissue-agnostic efficacy of the monoclonal anti-PD1 antibody, nivolumab, in patients with advanced or metastatic rare tumors. The study aims to treat rare malignancies with PD-L1 expression (CPS ≥ 10), regardless of the tumor's tissue type or location. Patients who have not responded to standard treatments will be included, and ...